Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 1191 composition records across product categories including Food and drug, Personal care, Cleaning products and household care.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of POLYOXYL 40 HYDROGENATED CASTOR OIL in our catalog (epa_cpdat).
Products
1,191
Brands
6
Typical roles
Catalog
Co-occurrence
Ingredients that frequently appear alongside POLYOXYL 40 HYDROGENATED CASTOR OIL in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 1191 composition records across product categories including Food and drug, Personal care, Cleaning products and household care. EPA CPDat classifies this chemical for functional uses including Surfactant (surface active agent), Emulsifier, Softener and conditioner.
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 20 %w/v
US
FDA
Effaclar
La roche-posay
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: TOPICAL; Dosage form: CREAM; Potency: 1.9 %w/w
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 352 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 3 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.53 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 3319 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED; Potency: 101.25 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 3240 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 120 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 50 mg
US
FDA
FDA NDC lists this ingredient in 5 drug products and 5 package presentations.
US
FDA
openFDA substance registry classifies this ingredient as structurallydiverse.